Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma

You Quan Li, Ni Sann Khin and Melvin L.K. Chua
Cancer Biology & Medicine February 2018, 15 (1) 1-5; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0176
You Quan Li
1Division of Radiation Oncology, National Cancer Center, Singapore 169610, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ni Sann Khin
1Division of Radiation Oncology, National Cancer Center, Singapore 169610, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melvin L.K. Chua
1Division of Radiation Oncology, National Cancer Center, Singapore 169610, Singapore
2Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore 169547, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Melvin.chua.l.k{at}singhealth.com.sg
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    1

    Summary of NPC screening studies.

    StudySample sizeScreening markerResults
    Zeng et al.712,932VCA/IgA and EA/IgA39 NPC detected;
    PPV for VCA/IgA & EA/IgA 1.0%;
    PPV for VCA/IgA 1.9%
    Zong et al.852,450VCA/IgA136 NPC detected;
    Sensitivity 97.84%;
    Specificity 93.59%;
    PPV 4.82%;
    NPV 99.99%
    Chien et al.99,699VCA/IgA and EBV DNase neutralising22 NPC detected;
    Sensitivity of VCA/IgA 18%;
    Specificity of VCA/IgA 98%;
    PPV of VCA/IgA 3%;
    NPV of VCA/IgA 99%
    Sensitivity of Anti-EBV DNAse 31%;
    Specificity of Anti-EBV DNAse 88%;
    PPV of Anti-EBV DNAse 0.6%;
    NPV of Anti-EBV DNAse 99%
    Cao et al.1018,986VCA/IgA & EA/IgA125 NPC detected;
    Sensitivity 33.6%;
    Specificity 93.0%;
    PPV 3.0%;
    NPV 99.5%
    Ji et al.17862EBNA1/IgA & VCA/IgA; EBV DNA33 NPC detected;
    Sensitivity of EBV DNA 86.8%;
    Specificity of EBV DNA 90%;
    PPV of EBV DNA 30%;
    NPV of EBV DNA 99.3%
    Chan et al.161,318VCA/IgA & EBV DNA3 NPC detected;
    Sensitivity of EBV DNA 100%;
    Specificity of EBV DNA 98.7%;
    PPV of EBV DNA 15%;
    NPV of EBV DNA 100%
    Chan et al.1820,174EBV DNA34 NPC detected;
    Sensitivity 97.1%;
    Specificity 98.6%;
    PPV 11.0%;
    NPV 99.9%

    PPV: positive predictive value; NPV: negative predictive value.

    PreviousNext
    Back to top

    In this issue

    Cancer Biology and Medicine: 15 (1)
    Cancer Biology & Medicine
    Vol. 15, Issue 1
    1 Feb 2018
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Email Article

    Thank you for your interest in spreading the word on Cancer Biology & Medicine.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    (Your Name) has sent you a message from Cancer Biology & Medicine
    (Your Name) thought you would like to see the Cancer Biology & Medicine web site.
    Citation Tools
    The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    You Quan Li, Ni Sann Khin, Melvin L.K. Chua
    Cancer Biology & Medicine Feb 2018, 15 (1) 1-5; DOI: 10.20892/j.issn.2095-3941.2017.0176

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    You Quan Li, Ni Sann Khin, Melvin L.K. Chua
    Cancer Biology & Medicine Feb 2018, 15 (1) 1-5; DOI: 10.20892/j.issn.2095-3941.2017.0176
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      •  
      • EBV and nasopharyngeal carcinoma
      • Historical studies using EBV serology
      • The meteoric rise of circulating EBV DNA in NPC
      • Future of EBV DNA and cf tumor DNA technologies in head and neck cancers
      • Acknowledgements
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • References
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • No citing articles found.
    • Google Scholar

    More in this TOC Section

    • Cancer nanomedicine for therapy: emerging strategies and expanding perspectives
    • Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide
    • Advances in TROP2-targeted antibody-drug conjugates for breast cancer therapy: into the new era
    Show more Editorial

    Similar Articles

    Keywords

    • Epstein-barr virus
    • nasopharynx cancer
    • detection
    • screening
    • prognostication

    Navigate

    • Home
    • Current Issue

    More Information

    • About CBM
    • About CACA
    • About TMUCIH
    • Editorial Board
    • Subscription

    For Authors

    • Instructions for authors
    • Journal Policies
    • Submit a Manuscript

    Journal Services

    • Email Alerts
    • Facebook
    • RSS Feeds
    • Twitter

     

    © 2026 Cancer Biology & Medicine

    Powered by HighWire